Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion type Assertion NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_head.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion description "[Our findings provide the scientific rationale supporting a novel clinical application for APOE genotyping as a means of identifying a genetic subgroup of dyslipidemic patients set to derive the greatest benefit from early lifestyle-based interventions aimed at decreasing cumulative risk for cardiovascular disease and prevention of AD later in life.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_provenance.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion evidence source_evidence_literature NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_provenance.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion SIO_000772 25731628 NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_provenance.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion wasDerivedFrom befree-2016 NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_provenance.
- NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_assertion wasGeneratedBy ECO_0000203 NP1267485.RAwPgr5_EkyiYJ7oyzHIITKM42unWr-DaKqP4K889OJLA130_provenance.